European Medicines Agency Recommends Use Of Fibrates As Second-line Treatment
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has concluded that the benefits of the four fibrates bezafibrate, ciprofibrate, fenofibrate and gemfibrozil continue to outweigh their risks in the treatment of patients with blood lipid disorders…
October 24, 2010 · by · in Nutritional News · Tags: benefits, blood-lipid, chmp, committee, european, european-medicines, fibrates-bezafibrate, human, medicinal, nutrition / diet, on call diets, risks, the-four, the-treatment, treatment
